 |
Quest PharmaTech Signs License Agreement with OncoCare Therapeutics to Develop and Commercialize Targeted Cancer Therapy Technology in the U.S. |
EDMONTON, ALBERTA, November 28, 2018 – Quest PharmaTech Inc., a biopharmaceutical company developing and commercializing products to improve the quality of life, today announced that it has entered into a license agreement with a U.S. company, OncoCare Therapeutics, to develop and commercialize the Company’s Targeted Cancer Therapy Technology in the U.S.